MESENCHYMAL STEM CELLS ISOLATED FROM PERIPHERAL BLOOD

The present invention relates to mesenchymal stem cells (MSC) isolated from peripheral blood, characterized in that said cells express the interleukin 13 receptor alpha-2 (IL13RA2), and also to a method for isolating said MSCs, which comprises detecting expression of said IL13RA2 in cells of a perip...

Full description

Saved in:
Bibliographic Details
Main Authors RUBIO AMADOR, RUTH, RODRIGUEZ MILLA, MIGUEL ANGEL, MASIP ORDONEZ, MANUEL, GARCIA CASTRO, JAVIER, CUBILLO MORENO, ISABEL MARIA, MARINAS PARDO, LUIS ANTONIO, RODRIGUEZ GONZALEZ, RENE, BLANCO MORON, ARMANDO, GARCIA ALCALDE, FERNANDO
Format Patent
LanguageEnglish
French
Spanish
Published 18.10.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to mesenchymal stem cells (MSC) isolated from peripheral blood, characterized in that said cells express the interleukin 13 receptor alpha-2 (IL13RA2), and also to a method for isolating said MSCs, which comprises detecting expression of said IL13RA2 in cells of a peripheral-blood sample and, if required, isolating said cells that express IL13RA2. La presente invención se relaciona con células madre mesenquimales (CMM) aisladas a partir de la sangre periférica, caracterizadas porque expresan el receptor alfa-2 de la interleuquina 13 (IL13RA2), así como con un método para aislar dichas CMM que comprende detectar la expresión de dicho IL13RA2 en células de una muestra de sangre periférica, y, si se desea, aislar dichas células que expresan IL13RA2. La présente invention concerne des cellules mères mésenchymateuses (CMM) isolées à partir de sang périphérique, caractérisées en ce qu'elles expriment le récepteur alpha-2 de l'interleukine 13 (IL13RA2), ainsi qu'un procédé pour isoler lesdites CMM qui consiste à détecter l'expression dudit récepteur IL13RA2 dans des cellules d'un échantillon de sang périphérique, et, au besoin, à isoler lesdites cellules qui expriment le récepteur IL13RA2.
Bibliography:Application Number: WO2011ES70844